The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy (TOPBLOC)

August 16, 2016 updated by: Morten Rune Blichfeldt-Eckhardt, Odense University Hospital

The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy.

The purpose of this study was to test whether peroperative infiltration of the phrenic nerve during lung surgery would protect patients against postoperative shoulder pain.

Study Overview

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region of Southern Denmark
      • Odense, Region of Southern Denmark, Denmark, 5000
        • Departement of Anaesthesia and intensive care, Odense University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients planned for elective lobectomy or pneumonectomy
  2. 18 years or more on the day of the operation
  3. Danish skills appropriate for fulfilling preoperative questionnaires

Exclusion Criteria:

  1. Known contralateral paresis of the Phrenic nerve
  2. Allergy to Ropivacaine or Sodium Chloride
  3. Preoperative ipsilateral shoulder pain
  4. Infection or eczema on the intervention site. Clinical decision
  5. Dementia or similar cerebral condition that makes the subject unable to perform a NRS-score of pain. Determined by clinical evaluation
  6. Pregnancy
  7. Acute porphyria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Ropivacaine
Phrenic nerve block with Ropivacaine
Other Names:
  • Naropin
PLACEBO_COMPARATOR: Placebo
Phrenic nerve block with Sodium chloride
Other Names:
  • Sodium Chloride

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder pain within 6 hours after the operation
Time Frame: Retrospective numerical rating scale, 6 hours after the operation
Shoulder pain 6 hours after the operations. Number of patients and numeric rating scale score (0-10)
Retrospective numerical rating scale, 6 hours after the operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with shoulder pain during the first 3 postoperative days.
Time Frame: Postoperative days 0-3
Postoperative days 0-3
NRS for shoulder pain during the first 3 postoperative days.
Time Frame: Postoperative days 0-3
NRS=numerical rating scale score 0-10
Postoperative days 0-3
Opioid use during the first 3 postoperative days
Time Frame: Postoperative day 0-3
Morphine equivalents
Postoperative day 0-3
Time spent in the recovery room
Time Frame: Measured at discharge from the recovery room. Estimated to be on postoperative day 0 or 1.
Measured at discharge from the recovery room. Estimated to be on postoperative day 0 or 1.
Shoulder pain 3 months postoperatively
Time Frame: 3 months postoperatively
3 months postoperatively
NRS for shoulder pain 3 months postoperatively
Time Frame: 3 months postoperatively
NRS=numerical rating scale 0-10
3 months postoperatively
Thoracic pain 3 months postoperatively
Time Frame: 3 months postoperatively
3 months postoperatively
NRS for thoracic pain 3 months postoperatively
Time Frame: 3 months postoperatively
NRS=numerical rating scale 0-10
3 months postoperatively
opioid use 3 months postoperatively
Time Frame: 3 months postoperatively
3 months postoperatively
Shoulder function 3 months postoperatively
Time Frame: 3 months postoperatively
Measured by DASH-score before the operation and after 3 months
3 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Morten R Blichfeldt-Eckhardt, MD, Departement of anaesthesia and intensive care, Odense University Hospital, Odense, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (ACTUAL)

July 1, 2014

Study Completion (ACTUAL)

July 1, 2014

Study Registration Dates

First Submitted

June 18, 2014

First Submitted That Met QC Criteria

June 23, 2014

First Posted (ESTIMATE)

June 25, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

August 17, 2016

Last Update Submitted That Met QC Criteria

August 16, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Phrenic nerve block with Ropivacaine

3
Subscribe